U.S. Sleep Aids Market Size & Outlook, 2026-2033
Related Markets
U.S. sleep aids market highlights
- The U.S. sleep aids market generated a revenue of USD 14,675.9 million in 2025 and is expected to reach USD 26,757.9 million by 2033.
- The U.S. market is expected to grow at a CAGR of 7.9% from 2026 to 2033.
- In terms of segment, medications was the largest revenue generating product type in 2025.
- Sleep Environment Products is the most lucrative product type segment registering the fastest growth during the forecast period.
Sleep aids market data book summary
| Market revenue in 2025 | USD 14,675.9 million |
| Market revenue in 2033 | USD 26,757.9 million |
| Growth rate | 7.9% (CAGR from 2026 to 2033) |
| Largest segment | Medications |
| Fastest growing segment | Sleep Environment Products |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Medications, Sleep Therapy Devices, Sleep Environment Products, Sleep Laboratory & Diagnostic Services |
| Key market players worldwide | Merck KGaA, Pfizer Inc, Sanofi SA, GSK PLC, Takeda Pharmaceutical Co Ltd, Teva Pharmaceutical Industries Ltd, Koninklijke Philips NV, ResMed Inc, Fisher & Paykel Healthcare Corp Ltd, Drive DeVilbiss Healthcare France, Compumedics Ltd., Cadwell Laboratories, Tempur Sealy International Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 29.9% of the global sleep aids market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. sleep aids market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 7,219.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sleep Aids Market Scope
Sleep Aids Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Compumedics Ltd. | View profile | - | - | - |
| Cadwell Laboratories | View profile | 51-100 | Kennewick, Washington, United States, North America | https://www.cadwell.com |
| Tempur Sealy International Inc | View profile | 13500 | 1000 Tempur Way, Lexington, KY, United States, 40511 | https://www.tempursealy.com |
| Drive DeVilbiss Healthcare France | View profile | 101-250 | Frouard, Lorraine, France, Europe | http://www.drivedevilbiss.fr |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Fisher & Paykel Healthcare Corp Ltd | View profile | 6584 | 15 Maurice Paykel Place, East Tamaki, Auckland, NTL, New Zealand, 2013 | https://www.fphcare.com |
| ResMed Inc | View profile | 10140 | 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 | https://www.resmed.com |
| Koninklijke Philips NV | View profile | 73712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | https://www.philips.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
U.S. sleep aids market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sleep aids market will help companies and investors design strategic landscapes.
Medications was the largest segment with a revenue share of 39.25% in 2025. Horizon Databook has segmented the U.S. sleep aids market based on medications, sleep therapy devices, sleep environment products, sleep laboratory & diagnostic services covering the revenue growth of each sub-segment from 2021 to 2033.
- U.S. Sleep Aids Product Type Outlook (Revenue, USD Million, 2021-2033)
- Medications
- Sleep Therapy Devices
- Positive Airway Pressure (PAP) Devices
- Oral Appliances
- Wearable Sleep Trackers
- Sleep Environment Products
- Sleep Laboratory & Diagnostic Services
- U.S. Sleep Aids Disorder Type Outlook (Revenue, USD Million, 2021-2033)
- Insomnia
- Obstructive Sleep Apnea (OSA)
- Narcolepsy
- Parasomnias (e.g., Sleepwalking, Night Terrors)
- Restless Legs Syndrome (RLS)
- Other Sleep Disorders
- U.S. Sleep Aids Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce Platforms
- Drug Stores
Reasons to subscribe to U.S. sleep aids market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. sleep aids market databook
-
Our clientele includes a mix of sleep aids market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. sleep aids market , including forecasts for subscribers. This country databook contains high-level insights into U.S. sleep aids market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
US Product Type - Sleep Aids Market size, 2025 - 2033 (US$M)
U.S. Sleep Aids Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
